DEXTROSE injection, solution

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Ingredientes ativos:

DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK)

Disponível em:

Vedco

Via de administração:

INTRAVENOUS

Tipo de prescrição:

OTC

Indicações terapêuticas:

For use as an aid in the treatment of acetonemia (Ketosis) in cattle. FOR ANIMAL USE ONLY

Resumo do produto:

ABILIFY® (aripiprazole) Tablets have markings on one side and are available in the strengths and packages listed in Table 15. ABILIFY DISCMELT® (aripiprazole) Orally Disintegrating Tablets are round tablets with markings on either side. ABILIFY DISCMELT is available in the strengths and packages listed in Table 16. ABILIFY® (aripiprazole) Oral Solution (1 mg/mL) is supplied in child-resistant bottles along with a calibrated oral dosing cup. ABILIFY Oral Solution is available as follows: ABILIFY® (aripiprazole) Injection for intramuscular use is available as a ready-to-use, 9.75 mg/1.3 mL (7.5 mg/mL) solution in clear, Type 1 glass vials as follows: Tablets Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Oral Solution Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Opened bottles of ABILIFY Oral Solution can be used for up to 6 months after opening, but not beyond the expiration date on the bottle. The bottle and its contents should be discarded after the expiration date. Injection Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Protect from light by storing in the original container. Retain in carton until time of use.

Status de autorização:

unapproved drug other

Folheto informativo - Bula

These highlights do not include all the information
needed to use ABILIFY safely and effectively. See full
prescribing information for ABILIFY.ABILIFY® (aripiprazole)
TabletsABILIFY DISCMELT® (aripiprazole) Orally Disintegrating
TabletsABILIFY® (aripiprazole) Oral SolutionABILIFY®
(aripiprazole) Injection FOR INTRAMUSCULAR USE ONLY Initial U.S.
Approval: 2002

/* */

ABILIFY -
aripiprazole tablet  H.J. Harkins
Company, Inc.
----------

MEDICATION GUIDE

ABILIFY® (a BIL )
Generic name: aripiprazole
Read this Medication Guide before you start taking ABILIFY
and each time you get a refill. There may be new information.
This Medication Guide does not take the place of talking to your
healthcare provider about your medical condition or
treatment.
What is the most important information
I should know about ABILIFY?
(For other side e

Leia o documento completo

Características técnicas

DEXTROSE- DEXTROSE INJECTION, SOLUTION
VEDCO
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
DEXTROSE 50% SOLUTION
DEXTROSE- DEXTROSE INJECTION, SOLUTION
VEDCO
DISCLAIMER: THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND
EFFECTIVE, AND THIS LABELING HAS
NOT BEEN APPROVED BY FDA.
DEXTROSE 50% SOLUTION
KEEP OUT OF REACH OF CHILDREN
ACTIVE INGREDIENTS:
EACH 100 ML CONTAINS:
Dextrose . H O .......................... 50 gms.
DOSAGE AND ADMINISTRATION:
For intravenous administration only.
CATTLE: 100 to 500 mL depending on size and condition.
Treatment may be repeated in several hours or on successive days as
needed.
STORAGE
STORE AT 15 DEGREES C TO 30 DEGREES C (59 DEGREES F-86 DEGREES F).
INDICATIONS:
For use as an aid in the treatment of acetonemia (Ketosis) in cattle.
CAUTION:
Intravenous administration must be done slowly and made under strict
asepsis. Solution should be
warmed to body temperature prior to administration.
This is a single dose container. This product contains no
preservative. After a quantity has been
withdrawn for injection, the remainder should be discarded. Do not
administer intraperitoneally.
FOR ANIMAL USE ONLY
TAKE TIME OBSERVE LABEL DIRECTIONS
Distributed By
VEDCO, INC.
2
St. Joseph, MO 64507
Made in El Salvador
TABLE
CONTENTS
NDC
VINV #
500 mL
50989-880-16
VINV-DEXT-ROUN
PRINCIPAL DISPLAY PANEL
NDC50989-880-16
ULTIGIENE TERMINALLY STERILIZED
DEXTROSE 50% SOLUTIONS
NET CONTENTS: 500 ML
VEDCO
FOR ANIMAL USE ONLY
KEEP OUT OF REACH OF CHILDREN
DEXTROSE
dextrose injection, solution
PRODUCT INFORMATION
PRODUCT T YPE
OTC ANIMAL DRUG
ITE M CODE (SOURCE )
NDC:50 9 8 9 -8 8 0
ROUTE OF ADMINISTRATION
INTRAVENOUS
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
Vedco
DEXTRO SE MO NO HYDRATE (UNII: LX22YL0 8 3G) (ANHYDROUS DEXTROSE -
UNII:5SL0 G7R0 OK)
DEXTROSE
MONOHYDRATE
50 g
in 10 0 mL
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIP